Among the 10 sectors approved on Wednesday, the largest chunk of the incentives, at over Rs 57,000 crore, would go to automobile and automobile components businesses followed by ACC battery at over Rs 18,000 crore.
Pharma products, for which Rs 15,000-crore PLI was announced, include patented drugs, biopharmaceuticals, phytopharmaceuticals (herbal), drugs not made in India, cell based or gene therapy products and orphan drugs (for very rare diseases) among others.
The scheme will be implemented by the respective ministries and departments.
However, the final proposals of PLI for individual sectors will be appraised by the Expenditure Finance Committee (EFC) and approved by the Cabinet within 45 days, sources said.
While industry players are still waiting for the fine print, many business leaders welcomed the scheme. Pankaj Patel, chairman of Cadila Healthcare, said the scheme was a step in the right direction. “Pharmaceuticals is a sector of strategic importance and thus any scheme that encourages indigenous research, high value product development is a welcome step.” Uday Kotak, president, Confederation of Indian Industry (CII), called the policy transformational and timely. It would facilitate India becoming a global manufacturing hub, according to Kotak. T V Narendran, managing director, Tata Steel, said with the government extending the scheme to 10 champion sectors, the country’s manufacturing growth was bound to catch more pace.
Savings, if any, from one PLI scheme
of an approved sector can be utilized to fund that of another sector approved by the empowered group of secretaries. Any new sector to be included under the PLI scheme
will require fresh approval of the Cabinet.
Briefing reporters after the Cabinet meeting, Finance Minister Nirmala Sitharaman said, “We are yet again proving that the policy that we are taking up even in PLI through which we want manufacturers to come to India is clearly to say we want to build on our strength but yet link with the global value chains.”
“... so this PLI is also aimed at getting investments into the country. These financial incentives will make it attractive to produce in India and the selection of sectors has been based on that," she said.
PLI in ACs is aimed at cutting down over Rs 15,000 crore worth of import of components annually. Of the Rs 22,000-crore AC market in India, only about 30 per cent value is added locally, according to estimates by industry bodies such as Consumer Electronics and Appliances Manufacturers Association (CEAMA).
However, LED has been a bone of contention between India and China. Nobody manufactures LED panels in India and continues to be imported. This makes up for over 60 per cent of the cost of making any LED TV. With Covid impacting the supply chain, the price of these panels has gone up by up to 120 per cent, adversely affecting companies operating in India (both global and local brands). In fact, all major brands, including Chinese, had to raise prices by 15-20 per cent between July and September.
Kamal Nandi, president of CEAMA and business head & executive vice president of Godrej Appliances, said, "We are committed to promoting domestic manufacturing of appliances and consumer electronics in the country. PLI will assist in the necessary boost to the ‘Make in India’ initiative and support India into becoming a manufacturing hub."
Textiles players want small companies to be also brought under PLI. Raja N Shanmugam, president of the Tirupur Exporters’ Association, said that giving a thrust to grow the man made fibre (MMF) and technical textiles arena had significant prospects.
On food products, PLI worth Rs 10,900 crore will be provided to boost local manufacturing in sectors like ready to eat, ready to cook (RTE/RTC), fruits & vegetables, honey, desi ghee, organic eggs and poultry meat, marine products etc.